about
Highlights on distinctive structural and functional properties of HTLV Tax proteinsClinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesisHTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoterThe bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcriptionCloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genomeSFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamilyHUB1, a novel Krüppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expressionHuman T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alphaHTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complicationsIsolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type IT helper cell activation and human retroviral pathogenesisLong-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionHuman T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite thExacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriersIncreased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue diseaseHuman T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)P-TEFb goes viralMolecular Mechanisms of HTLV-1 Cell-to-Cell TransmissionThe Role of HBZ in HTLV-1-Induced OncogenesisBlood-brain barrier and retroviral infectionsControversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of researchMechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virusHuman T-lymphotropic virus-1 visualized at the virological synapse by electron tomographyCrystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteinsCiclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesisEpidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central ChinaRat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells.Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathyRetroviruses and human disease.Isolation and characterization of simian T-cell leukemia virus type II from New World monkeysTreatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted TherapyEpigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.A public HTLV-1 molecular epidemiology database for sequence management and data mining.Analysis of human T-cell leukemia virus type 1 particles by using cryo-electron tomography.Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).Transmission of human T-cell lymphotropic virus type 1 tax to rabbits by tax-only-positive human cells.Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease?High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease
P2860
Q21131117-8D9670A2-0276-4C34-8AF8-E3F554C4EF79Q21131133-D851B2A2-D98F-4D60-B1B4-BCDB2876C648Q21134702-CC872B8F-A701-4793-9097-4476A7D32A05Q24301990-EFF8BEEA-2BD2-4C7A-A779-8CCA398D60D0Q24309545-8C2EE385-E8D4-4868-AB3E-A21D43BF04E9Q24310639-0F0AF07E-32CC-48D9-9114-7B9B7C8E2C3BQ24312994-CB01EFAA-B556-4367-AC31-EF8CE8AD9BE7Q24525274-574C777E-1D90-4F99-86DF-65D7B138FAE4Q24607794-3CD7B958-1780-4083-996E-6F76EEDA4463Q24648442-0BF23040-D97D-4E96-8118-D5A1EA86CBD9Q24650854-99889FB7-1A6E-41E2-910E-A1250840466BQ24658333-47DA429E-E5ED-4F54-A766-E66F7A4A78FCQ24671809-258F293D-0071-4744-B07C-83EDEFBDB428Q24803711-4D494286-8E4B-43C8-B9B7-875047673768Q24805302-2B1334BD-5D8A-4C56-90E8-7BAB9F53EE4EQ24805664-315A8B1D-8156-495C-865D-90598D54F5C9Q26741360-320ADBD4-3925-4031-A7F0-6703BDA68F4BQ26752562-F2A5B041-1640-4CDE-BB05-174D1FBE421DQ26768630-91024A47-6D4E-4981-8493-219F808D8507Q26830903-EF1D486A-2FE3-432E-9708-703A51C638E8Q26852683-C1B9C6C7-507D-4E8B-A993-8EE08DD3E370Q26853678-D3AAE7B6-3CFF-40D0-BCC9-49A930FFD057Q26863681-CBF57756-0142-411B-BCA9-5440DCCB723FQ27301309-FCA38878-EE13-4365-B87E-55C072D99E0AQ27617901-8220DBDE-5199-4C43-8DC9-07B6CC7FE21AQ28484214-B6B8000C-2D00-4618-A69A-91C70D14D9BEQ28534288-5648AE57-93DB-4F4D-B650-093F34C2299DQ28564663-C92C54D4-0B36-4B87-AEE7-C9A21523C699Q28727305-60EE56D2-5206-4E3B-B8B4-F6CA6AE6DE3EQ28769657-C6EF8A96-8937-4FBF-9F13-9CFD17CDBFBAQ28776767-86D9B4F4-7120-4982-9C6A-D5F246CE618FQ28972318-E70ACDAD-4C4F-45D5-A348-3CA5F882C8AFQ30371156-035A3BFA-0C89-414B-85B8-DA1842BD4D6BQ30425683-6DC7D177-E270-4AEB-8F14-882B7A2A041AQ30485688-962289F6-D590-4057-8A4F-B9FD0F25EFB0Q30621111-4F96FC9B-8AA8-4AA6-AECA-D57483FE42A8Q30698124-4D728230-7C7C-4068-BBF6-D358DC2B9C28Q30797529-58B9F086-6B30-43E4-AEC0-9449455CCBA6Q30913837-B530074B-7B6D-42B9-AA5F-F6DF159250C4Q30973354-15225457-175A-43F6-AC41-1C6DCC958BCF
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
HTLV-I associated myelopathy, a new clinical entity.
@en
HTLV-I associated myelopathy, a new clinical entity.
@nl
type
label
HTLV-I associated myelopathy, a new clinical entity.
@en
HTLV-I associated myelopathy, a new clinical entity.
@nl
prefLabel
HTLV-I associated myelopathy, a new clinical entity.
@en
HTLV-I associated myelopathy, a new clinical entity.
@nl
P2093
P1433
P1476
HTLV-I associated myelopathy, a new clinical entity.
@en
P2093
M Matsumoto
P304
P356
10.1016/S0140-6736(86)91298-5
P407
P577
1986-05-01T00:00:00Z